New and Emerging Treatments for Epilepsy: Review of Clinical Studies of Lacosamide, Eslicarbazepine Acetate, Ezogabine, Rufinamide, Perampanel, and Electrical Stimulation Therapy
Journal of Epilepsy Research · 2011
DOI: 10.14581/jer.11008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Epilepsy Research, 2011. Verfasst von Steve S Chung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Zitieren
APA
Chung, S. S., Kelly, K., & Schusse, C. (2011). New and Emerging Treatments for Epilepsy: Review of Clinical Studies of Lacosamide, Eslicarbazepine Acetate, Ezogabine, Rufinamide, Perampanel, and Electrical Stimulation Therapy. Journal of Epilepsy Research. https://doi.org/10.14581/jer.11008
Vancouver
Chung SS, Kelly K, Schusse C. New and Emerging Treatments for Epilepsy: Review of Clinical Studies of Lacosamide, Eslicarbazepine Acetate, Ezogabine, Rufinamide, Perampanel, and Electrical Stimulation Therapy. Journal of Epilepsy Research. 2011. doi:10.14581/jer.11008
BibTeX
@article{Chung2011,
author = {Chung, Steve S and Kelly, Kristen and Schusse, Courtney},
title = {New and Emerging Treatments for Epilepsy: Review of Clinical Studies of Lacosamide, Eslicarbazepine Acetate, Ezogabine, Rufinamide, Perampanel, and Electrical Stimulation Therapy},
journal = {Journal of Epilepsy Research},
year = {2011},
doi = {10.14581/jer.11008}
}
EUVIMED